Attend

 

 

World Vaccine Congress Europe

ADVANCING THE SCIENCE AND STRATEGY OF THE WORLD’S FUTURE VACCINES
 

 

About the World Vaccine Congress

The 19th Annual World Vaccine Congress is the place where the global vaccine industry meets to discuss commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging diseases and veterinary vaccines.

Across 130 sessions, you will learn from leading experts across the issues most impacting on the wider vaccine sector, as well as delve into your specialist area of research and job focus in co-located conferences. Build three days of totally tailored content and attendees.


Who Sponsors?

  • Big Pharma 
  • Biotechs 
  • Contract Research Organizations 
  • Contract Manufacturing Organizations 
  • OEMs / Equipment Manufacturers 
  • Platform Technology Providers 
  • Logistics / Cold Chain 
  • Clinical Trial Site / Networks


Who Attends

CEOs, CSOs, Directors and Heads from:

  • Big Pharma 
  • Biotechs 
  • National and International Government 
  • Non-Profit Organizations 
  • Academics And Research Institutions
World Veterinary Vaccine Congress Europe


SCIENCE, STRATEGY AND PARTNERSHIPS FOR THE VETERINARY VACCINE SECTOR
 

 

A two day event with a pre-event workshop where the global animal health industry meets to discuss scientific, regulatory and commercial issues from new innovative vaccine technologies to emerging disease.

New Vaccine Technology and Platforms

Focused on R&D innovations, this congress will update you of the progression made in veterinary vaccine R&D and vaccine development challenges when developing vaccines against viral, bacterial and parasitic diseases within a variety of animal species. From modified live virus vaccines, DNA vaccines, subunit marker vaccines to novel adjuvanted vaccines, this congress brings all innovation together in one place.

Industry Insights and Market Trends

Bridge the gap between animal and human health with a one health approach to control emerging diseases in a changing world. Hear from regulators who can advise you on what they are looking for when assessing new platforms for registration.

Developing and Formulating New Vaccines

From novel combination adjuvants for veterinary vaccines to making vaccines more affordable, meet experts who can delve into process improvements approaches when developing new vaccines.

Antimicrobial Resistance and Emerging Diseases

Expect the unexpected, explore the opportunities and challenges associated with emerging infectious diseases including African swine fever, avian influenza and Rift Valley Fever. Find out how the industry is working together to find alternative routes (vaccines) to slow down the rise of antimicrobial resistance.

One Health

Be part of the 19th World Vaccine Congress too as this track is fully integrated into the main conference agenda, meaning all professionals concerned with human and veterinary vaccines will have the opportunity to learn and liaise more directly than ever before! Discuss the upcoming emerging diseases risks, pathogen identification and global efforts made towards achieving one health.

Immuno Oncology Profiling Congress 2018

LEARN, DISCOVER AND NETWORK WITH IMMUNE PROFILING EXPERTS
 

 

With newer and more advanced immune profiling technologies, we are getting to understand the human immune system more and more. From infection, vaccination to how disease or pathogens alters immune cell repertoires and their functional activities. This congress brings together experts to discuss how profiling of the immune system using high throughput technologies, can aid therapeutic design and treatment strategies in infectious and non-infectious diseases.

Cancer Vaccines & Antibodies

Discover how cancer vaccines and antibody therapies are advancing clinically from leading biotechs and pharma. With every trial becoming combinational, the distinction between different immunotherapy treatments is merging – learn how your treatment can be integrated into other indications for better clinical efficacy and patient outcome

Characterisation of the Immuneresponse

Learn about the dual role of biomarkers for understanding basic principles and devising novel intervention strategies, as well as optimized immune profiling by understanding T-cell and B-cell repertories during cancer

Immunosequencing and High Throughput Analysis

Hear key thought leaders on Predictive & Precision medicine: Diagnostic testing, biomarkers and immunoassay systems; Immunosequencing: Combining high throughput sequencing and bioinformatics to profile T-cell and B-cell receptors; Single-cell technologies: Validating discoveries and translating them into clinically useful diagnostic assays; Utilising next generation sequencing for fast and accurate processing of sequencing data from T- and B- cell receptor libraries; Developing novel antibody immunotherapies that help the immune system attack diseased cells

Immunotherapy and Profiling in Cancer

Gain insight into next generation of immune checkpoint inhibitors; Direct identification of neoepitopes for cancer vaccines and adoptive T-Cell therapies; Next generation CAR Technology: Amplifying the immune response within the tumour microenvironment; Identifying immunogenic mutations to create immune diagnostics and effective immune monitoring of patients.

 

BIOPROCESSING AND MANUFACTURING

 

About the Bioprocessing & Manufacturing Tracks

With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale.

Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing.


Who Sponsors?

  • CMOs
  • Fill / Finish 
  • Finished Dosage 
  • Platform Technology Providers
  • Big Pharma
  • Biotech


Who Attends

  • Pharma 
  • Biotech
  • National and International Government
  • Academics and Research Institutions


Job Titles

  • Head of Bioprocessing 
  • Head of Manufacturing 
  • Head of Formulation 
  • Head of Biopharmaceutical Development 
  • Head of Upstream / Downstream Process
  • Head of R&D 
  • Head of Procurement 
  • Head of CMC

INFLUENZA AND RESPIRATORY

 

About the Influenza and Respiratory Vaccine Tracks

This event will tackle the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. vaccines.

Ensure you use this event to make people aware of your expertise around key topics such as universal and seasonal flu, maternal immunization and pandemic preparedness.


Who Sponsors?

This is a key opportunity for specialists in influenza and respiratory vaccines from:

  • Platform Technology Providers
  • Biotechs
  • Big Pharma
  • Logistics / Cold Chain


Who Attends

  • Pharma 
  • Biotechs 
  • National and International Government 
  • Non-Profit Organizations 
  • Academics And Research Institutions


Job titles:

  • CEO / CSO / COO 
  • CMO / Head of Scientific Affairs
  • Head of Influenza
  • Head of Infectious Disease
  • Head of R&D
  • Head of Regulatory Affairs
  • Head of Manufacturing
  • Head of Immunology

EMERGING AND RE-EMERGING DISEASES

 

About the Emerging and Re-Emerging Diseases Tracks

The Zika and Ebola outbreaks brought emerging and reemerging diseases screaming into the limelight.

This brought with it a renewed vigor for vaccines from the public and a catalyst for the scientific community to progress vaccines for diseases such as as Zika, Ebola, Malaria, Dengue, and Chikungunya. Use this Conference to meet with and demonstrate your knowledge to the organizations who are pushing forward in this area.


Who Sponsors?

This is a great opportunity for specialists in emerging diseases from:

  • Platform Technology Providers
  • Logistics / Cold Chain
  • Big Pharma
  • Biotechs


Who Attends

  • Pharma 
  • Biotechs 
  • National and International Government 
  • Non-Profit Organizations 
  • Academics And Research Institutions


Job titles:

  • CEO / CSO / COO
  • CMO / Head of Scientific Affairs
  • Head of Infectious / Emerging / Neglected Disease
  • Head of R&D
  • Head of Virology
  • Head of Immunology
 

PRE-CLINICAL VALIDATION TO CLINICAL TRIALS

 

About the Pre-clinical to Clinical Trials Tracks

As new technologies and personalized vaccines become the norm, the dynamic of clinical trials has to evolve.

This focused clinical development conference will allow you to showcase your services to those who are looking to run new trial models, need support in choosing and gaining approval for different clinical endpoints and want to understand how to get the best out of the information collected.


Who Sponsors?

  • CROs
  • OEMs / Equipment Manufacturers 
  • Platform Technology Providers 
  • Big Pharma 
  • Biotech


Who Attends

  • Pharma 
  • Biotechs 
  • National and International Government 
  • Academics And Research Institutions


Job titles:

  • CEO / CSO / COO 
  • CMO / Head of Scientific Affairs 
  • Head of (Pre-) Clinical Development 
  • Head of Clinical Trial Management / Operations
  • Head of R&D

ANTI MICROBIAL RESISTANCE

 

About the Anti-Microbial Resistance Tracks

The impact of rising resistance has made the development of effective vaccines against otherwise lethal bacterial infections paramount.

While efforts towards developing new and effective antibiotics will take a number of years, vaccines could provide the immunity that could help us in catching up with the arms race.


Who Sponsors?

This is a prime opportunity for specialists in oncology from:

  • CROs and Pre-Clinical CROs 
  • Drug Discovery, Collaborative Data, Registries, Translational Science and Academia/Research Institutes 
  • Consultants (Reg/Mkt Access/Comm) 
  • Biopharma, Biotech, Biofilm 
  • Molecular Diagnostics, In-Vitro Diagnostics, Point-of- Care Diagnostics, Antimicrobial testing labs 
  • Bioinformatics, bioanalytics, biodata tech, biosimulation
  • Stewardship 
  • CMOs, Equipment, consumable


Who Attends

  • Pharma 
  • Biotechs 
  • Government 
  • Public Agencies & Associations
  • Academics And Research Institutions


Job titles:

  • CEO 
  • Chief/VP of R&D 
  • Head, SVP, VP, Director of Infectious Diseases 
  • President, Global Development 
  • VP, Clinical Development 
  • Chief Medical Officer 
  • VP of Microbiology 
  • VP of Antibacterial, Antibiotic 
  • Principal Investigators 
  • Scientists 
  • Strategic Alliance 
  • Alliance/Partnership Development 
  • VP of Microbiology

TECHNOLOGY

 

About the Technology Tracks

What novel platform technologies are going to shake the industry? With the burst of new Plug-and-Play platforms, responding to emerging diseases and unexpected outbreaks could be sufficiently contained in the future with minimum casualties - but what are these platforms and will they cover all of the possible unthinkable devastations, as experienced from Ebola and Zika? How will new platforms help patients that need personalised therapeutic vaccines?

Find out by coming to the new Vaccines Technology track, were we and the Scientific Advisory Board have hand selected what we think are some of the most promising platforms around. Each only 15 min long, each will showcase their technology and its clinical, manufacturing and commercial potential.


Who Sponsors?

  • CMOs 
  • Fill / Finish 
  • Finished Dosage 
  • Platform Technology Providers 
  • Big Pharma 
  • Biotechs


Who Attends

  • Pharma 
  • Biotechs 
  • National and International Government 
  • Public Agencies & Associations
  • Academics And Research Institutions


Job titles:

  • Head of Bioprocessing 
  • Head of Manufacturing 
  • Head of Formulation 
  • Head of Biopharmaceutical Development 
  • Head of Upstream / Downstream Process 
  • Head of R&D 
  • Head of Procurement 
  • Head of CMC
 
 
 



Excellent mix of basic, applied and translational vaccinology with good high level industry representation


Professor, University of South Australia